These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31573421)

  • 1. Noncommunicable diseases, access to essential medicines and universal health coverage.
    Beran D; Pedersen HB; Robertson J
    Glob Health Action; 2019; 12(1):1670014. PubMed ID: 31573421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Access to essential medicines to treat chronic respiratory disease in low-income countries.
    Bissell K; Perrin C; Beran D
    Int J Tuberc Lung Dis; 2016 Jun; 20(6):717-28. PubMed ID: 27155173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Access to medicines through health systems in low- and middle-income countries.
    Ozawa S; Shankar R; Leopold C; Orubu S
    Health Policy Plan; 2019 Dec; 34(Supplement_3):iii1-iii3. PubMed ID: 31816069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality use of medicines within universal health coverage: challenges and opportunities.
    Wagner AK; Quick JD; Ross-Degnan D
    BMC Health Serv Res; 2014 Aug; 14():357. PubMed ID: 25164588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The imperative for systems thinking to promote access to medicines, efficient delivery, and cost-effectiveness when implementing health financing reforms: a qualitative study.
    Achoki T; Lesego A
    Int J Equity Health; 2017 Mar; 16(1):53. PubMed ID: 28327143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Legislating for universal access to medicines: a rights-based cross-national comparison of UHC laws in 16 countries.
    Perehudoff SK; Alexandrov NV; Hogerzeil HV
    Health Policy Plan; 2019 Dec; 34(Supplement_3):iii48-iii57. PubMed ID: 31816073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of prospective pathways and impacts of COVID-19 on the accessibility, safety, quality, and affordability of essential medicines and vaccines for universal health coverage in Africa.
    Amimo F; Lambert B; Magit A; Hashizume M
    Global Health; 2021 Apr; 17(1):42. PubMed ID: 33832487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Household access to non-communicable disease medicines during universal health care roll-out in Kenya: A time series analysis.
    Kiragu ZW; Rockers PC; Onyango MA; Mungai J; Mboya J; Laing R; Wirtz VJ
    PLoS One; 2022; 17(4):e0266715. PubMed ID: 35443014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The right to health as the basis for universal health coverage: A cross-national analysis of national medicines policies of 71 countries.
    Perehudoff SK; Alexandrov NV; Hogerzeil HV
    PLoS One; 2019; 14(6):e0215577. PubMed ID: 31251737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.
    Ewen M; Zweekhorst M; Regeer B; Laing R
    PLoS One; 2017; 12(2):e0171284. PubMed ID: 28170413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Universal access to essential medicines as part of the right to health: a cross-national comparison of national laws, medicines policies, and health system indicators.
    Perehudoff K
    Glob Health Action; 2020 Dec; 13(1):1699342. PubMed ID: 33131456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Framing access to essential medicines in the context of Universal Health Coverage: a critical analysis of health sector strategic plans from eight countries in the WHO African region.
    Mhazo AT; Maponga CC
    BMC Health Serv Res; 2022 Nov; 22(1):1390. PubMed ID: 36419062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Availability, pricing and affordability of selected medicines for noncommunicable diseases.
    Heidari E; Varmaghani M; Abdollahiasl A
    East Mediterr Health J; 2019 Oct; 25(7):473-480. PubMed ID: 31612979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Universal health coverage and key populations.
    Macdonald V; Verster A; Seale A; Baggaley R; Ball A
    Curr Opin HIV AIDS; 2019 Sep; 14(5):433-438. PubMed ID: 31241544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How and why pharmaceutical reforms contribute to universal health coverage through improving equitable access to medicines: a case of Ghana.
    Koduah A
    Front Public Health; 2023; 11():1163342. PubMed ID: 37483923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gaps in access to essential medicines and health products for noncommunicable diseases and mental health conditions.
    Minghui R; Simao M; Mikkelsen B; Kestel D; Ball A; Szilagyi Z
    Bull World Health Organ; 2020 Sep; 98(9):582-582A. PubMed ID: 33012854
    [No Abstract]   [Full Text] [Related]  

  • 17. Mapping actions to improve access to medicines for mental disorders in low and middle income countries.
    Barbui C; Dua T; Kolappa K; Saraceno B; Saxena S
    Epidemiol Psychiatr Sci; 2017 Oct; 26(5):481-490. PubMed ID: 28067194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of health systems factors in facilitating access to psychotropic medicines: a cross-sectional analysis of the WHO-AIMS in 63 low- and middle-income countries.
    McBain R; Norton DJ; Morris J; Yasamy MT; Betancourt TS
    PLoS Med; 2012 Jan; 9(1):e1001166. PubMed ID: 22303288
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.